Epigenetics Market Research Report – Forecast to 2030

Epigenetics Market Size, Trends and Industry Analysis by Instruments (NGS, spectrometer, PCR, software solutions and others), by Consumables (kit, enzymes, reagent, and others), by Application (oncology, developmental biology, drug discovery, cardiology, immunology and others), by Technology (methylation, histone modification and others), by End Users (academia and research, pharmaceutical and biotechnology industry and others) - Forecast to 2030

ID: MRFR/LS/4703-HCR | 100 Pages | Published By Kinjoll Dey on March 2023         

Epigenetics Market Speak to Analyst Request a Free Sample

Epigenetics Market Overview:

Epigenetics market size is expected to reach USD 4.5 billion by 2030 at 15.8% CAGR during the forecast period 2022-2030. Epigenetics is the study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity and expression. The sources of heritable changes may be external from environmental factors, or internal factors such as age, disease and others. Examples of Epigenetics are DNA methylation and histone modification, which alters genes expression without altering the DNA sequence.

The drivers of epigenetics market are growing risk factors and the associated increase in cases of cancer, increase in the R&D activities, developing pharmaceutical, and biotechnology sectors, application expanse of epigenetics and others. The development of high sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a massive adoption. The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption.

The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth. Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the epigenetics market. Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others.

High growth of biotech and growing number of start-ups are driving the development of proprietary technology. According to national venture capital association, the Biotechnology industry received the second largest amount of venture capital for the year 2016 and ended with a 17% rise in dollars as compared with the previous year.

The prime market constraints include prohibitive costs of molecular diagnostics, ha high cost of manufacturing, consolidated nature of the market has put a premium on the price other f the epigenetics products, nascent stage of technology and high power of firms relative to buyers.

Key Vendors Operating In Epigenetics Market:

Some of the dominant vendors operating in the report are

  • Bio-Rad (US)

  • Illumina (US)

  • QIAGEN (Netherlands)

  • Thermo Fisher (US)

  • Active Motif (US)

  • Diagenode (Belgium)

  • Agilent (US)

  • Merck Millipore (US)

  • Abcam (UK)

  • New England Biolabs (US)

  • PerkinElmer (US)

  • Zymo Research (US).

Epigenetics Market Segments:

The epigenetics market is segmented based on instruments, consumables, applications, technology, end users, and regions.

Based on instruments, the market comprises of NGS, spectrometer, PCR, software solutions and others.

Based on consumables, the market comprises of kit, enzymes, reagent, and others.

Based on application, the market comprises of oncology, developmental biology, drug discovery, cardiology, immunology, and others.

Based on technology, the market comprises of methylation, histone modification, and others.

Based on end users the market is segmented into academia and research, pharmaceutical and biotechnology industry and others.

Based on the regions, the market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.

Epigenetics Market Regional analysis

North America is the largest market in 2016 with the U.S. in the lead position owing to the faster uptake of technology, the gigantic biotech industry of the U.S., the presence of global and technology players, which is propelling the molecular diagnostics industry.

Europe led by Germany, U.K., and France accounts for the second-largest and second fastest market during the forecasted period. Asia is anticipated to expand at the most rapid rate led by Japan, China, South Korea and India.

The Middle East and Africa market are anticipated to generate a moderate growth on account of the impoverished industry landscape and low demand due to weak economic conditions.

Intended Audience`1a`

  • Global epigenetics providers, manufacturers & suppliers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Academic institutes and universities

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 4.5 Billion
  CAGR   15.8%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   
  Report Coverage   
  Segments Covered   
  Geographies Covered   
  Key Vendors   
  Key Market Opportunities   
  Key Market Drivers   

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Epigenetics is the study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence.

Leading players in the Epigenetics Market include Illumina, Bio-Rad, and Thermo Fisher, among others.

Growing government support for advancements in biotechnology is the major driver for the Epigenetics Market.

North America is the largest regional market for epigenetics.

Major applications of epigenetics include oncology, immunology, cardiology, drug discovery, and developmental biology.